Signal category
Monitor how competitors respond to market openings, data releases, and regulatory milestones across key franchises.
Pipeline moves, positioning shifts, and competitive dynamics that change how assets are valued and prioritized.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.
Signal Score
8.4
Merck has published a method for the large-scale synthesis of enlicitide decanoate, an investigational oral PCSK9 inhibitor.
Signal Score
8.4
Roche has launched the Liver Disease Panel, a suite of certified algorithms aimed at improving the management of chronic liver disease (CLD). This panel includes the LiverPRO algorithm, which facilitates early detection of liver fibrosis using routine blood markers.